3.2 billion rubles will be invested in a new plant of blood plasma medicines

| By | Immuno-Gem, Pharmaceutical Plant Construction
News

A production facility for medicinal products based on human blood plasma will be built in St. Petersburg by investing about 3.2 billion rubles in the project, said Vyacheslav Reshetnik, the founder of Immuno-Gem, a company.

The official ceremony marking the laying of foundation stone for the new plant was held on March 23.

“We expect the construction works to take no more than two years, and we hope that we will have a year to produce first medicinal products… The investments will reach about 3.2 billion rubles,” said Mr. Reshetnik.

He added that it would be a full-cycle manufacturing enterprise.

“At this point, we can say that it will be a plant with the capacity of deep blood processing from start to finish,” said the founder of the company.

According to the project, the annual revenue of the enterprise will be 2.5 billion rubles, and the volume of expected output will reach 500,000 packages a year (blood substitutes, blood clotting factors, intravenous immunoglobulins, substance based on human blood proteins, and innovative medicinal products). The facility will provide highly effective and safe medicines to patients. In addition, it will create more than 200 new highly skilled jobs.